Observational studyBMJ open2025
Aetiologic diagnosis of thoracic granulomatous diseases: a retrospective multicentre study in South-Central China.
Observational study in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo characterise the aetiological spectrum of thoracic granulomatous diseases and identify diagnostic features that facilitate differentiation among causes.
designRetrospective multicentre observational study.
settingTwo tertiary hospitals in south-central China. Patient data were consecutively enrolled from 1 June 2020 to 30 June 2023.
participantsOf 2486 patients with pathologically confirmed thoracic granulomas initially identified, exclusions were applied for specimens outside the lung/pleura/mediastinum (579), incomplete demographic/imaging/pathology data (280) or lack of follow-up (231). A total of 1396 patients met all criteria (853 from hospital 1 and 543 from hospital 2) and were included in the final analysis. PRIMARY AND SECONDARY OUTCOME MEASURES: We quantified the aetiologic distribution of thoracic granulomatous diseases and examined age-stratified/lesion-location differences in aetiologic patterns. We also evaluated associations between histopathological features and specific aetiologies and compared the diagnostic accuracy across sampling modalities.
resultsAmong the 1396 enrolled cases, a confident, probable and uncertain diagnosis was made in 1086 cases, 307 cases and 84 cases. Infectious granulomas predominated (89.4%; 1248/1396), with tuberculosis comprising 87.8% (1096/1248) of infectious cases. Among non-infectious granulomas, sarcoidosis was most common (65.8%; 50/76). Patients aged ≥60 years had a higher proportion of infectious granulomas than younger groups (≥60 years: 389/422; 40-60 years: 633/714; <40 years: 226/260; p=0.044). Fungal granulomas were more frequent in those aged 40-59 years (10.9% of infectious granulomas). Diagnostic accuracy was highest for surgical biopsy (93.5%, 288/305), followed by thoracoscopy (92.3%, 108/117) and transbronchial lung biopsy (74.7%, 510/683). Necrosis was present in 88.6% of granulomas; positive special stains were strongly associated with fungal infection.
conclusionsMost thoracic granulomas arise from mycobacterial or fungal infection, while sarcoidosis is the leading non-infectious cause. Thoracoscopy and surgical biopsy show superior diagnostic yields, and special staining aids differentiation of fungal aetiologies. Findings support a multidisciplinary approach to improve diagnostic accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.